Caxton Associates (UK)’s Novanta NOVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NOVT
CCA
CAM
GKIM
Caxton Associates (UK)'s NOVT Position: Q2 2026 in Review
Caxton Associates (UK) sold out of Novanta (NOVT) in Q2 2026, closing a stake of 11,535 shares — an estimated $1.36M sold.
Caxton Associates (UK) first reported a position in NOVT in Q2 2025 and held it in 3 quarters. The position peaked at $1.36M in Q1 2026. 390 funds tracked by Wall St. Rank hold NOVT as of Q2 2026.
- Caxton Associates (UK) reported no remaining Novanta position as of Q2 2026 after selling out during the quarter.
- Caxton Associates (UK) sold 11,535 Novanta shares in Q2 2026, an estimated $1.36M.
- Caxton Associates (UK) first reported a position in Novanta in Q2 2025 and held it in 3 quarters.
- Caxton Associates (UK)'s Novanta position peaked at $1.36M in Q1 2026.
- 390 funds tracked by Wall St. Rank held Novanta as of Q2 2026.
Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.